MainBoardListed
Valiant Laboratories Limited
Company websiteSize: ₹1,15,56,000 crore. Fresh issue: ₹1,15,56,000 crore. OFS: ₹0 crore.
When to apply: 27-09-2023 — 03-10-2023. Allotment: 04-10-2023. Listing: 06-10-2023. Note: OFS does not raise fresh capital for the company.
Start Date27-09-2023
End Date03-10-2023
Listing Date06-10-2023
Allotment Date04-10-2023
Current Price₹162.15
GMP₹20 (14.29%)
Lot Size105 Shares
Subscription29.75 Times
Face Value₹10 per share
Listing atNSE, BSE
Issue Price₹133 - ₹140
Pre Issue₹3,25,60,000
Post Issue₹4,41,16,000
Issue Size₹1,15,56,000
(aggregating up to 152.00 Cr)
(aggregating up to 152.00 Cr)
Fresh Issue₹1,15,56,000
(aggregating up to 152.00 Cr)
(aggregating up to 152.00 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Valiant Laboratories Limited is currently around ₹20 (14.29%). This indicates an estimated listing price of approximately ₹153 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
06 Nov 2025, 06:56 | ₹140 | ₹20 | ₹160 (14.29%) |
18 Mar 2025, 09:25 | ₹140 | ₹20 | ₹160 (14.29%) |
Financials overview In Crores
Here is a quick look at the recent financial performance of Valiant Laboratories Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Values |
|---|---|
EPS | 8.91 |
ROE | 33.73 |
ROCE | 22.76 |
RONW | 28.86 |
PRE IPO(PE) | 15.71 |
POST IPO(PE) | 0 |
Subscription Demand (in ₹ Crore)
| Category | Offered | Demand | Times |
|---|---|---|---|
QIBs | ₹30.49 | 635.06 | 20.83 |
RETAIL | ₹53.36 | 856.39 | 16.05 |
HNIs 2+ | ₹7.62 | 485.02 | 63.65 |
HNIs 10+ | ₹15.25 | 1198.91 | 78.62 |
Total | ₹106.72 | 3175.38 | 29.75 |
The IPO reservation for Valiant Laboratories Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Retail | 35.00% | 38,11,500 |
NII(HNI) | 15.00% | 16,33,500 |
QIB | 50.00% | 54,45,000 |
TOTAL | 100.00% | 1,08,90,000 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 105 | ₹14,700 | |
sHNI | 14 | 1,470 | ₹2,05,800 | |
bHNI | 69 | 7,245 | ₹10,14,300 |
Below you can find the official contact details of Valiant Laboratories Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Phone: +91 2249712001
Website: https://valiantlabs.in/
Address: 104,Udyog Kshetra, Mulund Goregaon Link Road, Mulund West, Mumbai -400080
IPO Registrar
Name: Link Intime India Private Limited
Phone: +91-22-4918 6270